Financing immunizations in the United States

被引:63
作者
Hinman, AR
Orenstein, WA
Rodewald, L
机构
[1] Ctr Dis Control & Prevent, Task Force Child Survival & Dev, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA
关键词
D O I
10.1086/420748
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Children in the United States receive immunizations through both private and public sectors. The federal government has supported childhood immunization since 1963 through the Vaccination Assistance Act (Section 317 of the Public Health Service Act). Since 1994, the Vaccines for Children (VFC) program has provided additional support for childhood vaccines. In 2002, 41% of childhood vaccines were purchased through VFC, 11% through Section 317, 5% through state and/or local governments, and 43% through the private sector. The recent introduction of more-expensive vaccines, such as pneumococcal conjugate vaccine, has highlighted weaknesses in the current system. Adult immunization is primarily performed in the private sector. Until 1981, there was no federal support for adult immunization. Since 1981, Medicare has reimbursed the cost of pneumococcal vaccine for its beneficiaries; influenza vaccine was added in 1993. This paper summarizes the history of financing immunizations in the United States and discusses some current problems and proposed solutions.
引用
收藏
页码:1445 / 1451
页数:7
相关论文
共 52 条
[1]  
*ADV COMM IMM PRAC, 2003, MMWR RECOMM REP, V52, P1
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]  
[Anonymous], 1997, Morbidity and Mortality Weekly Report, V46, P1
[4]   THE IMPACT OF HEALTH-CARE FINANCING ON CHILDHOOD IMMUNIZATION PRACTICES [J].
ARNOLD, PJ ;
SCHLENKER, TL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (06) :728-732
[5]  
Atkinson William L., 1992, Morbidity and Mortality Weekly Report, V41, P1
[6]  
BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547
[7]   Do we need a structural engineer to redesign our vaccine infrastructure? [J].
Berman, S .
PEDIATRICS, 2003, 112 (03) :671-672
[8]  
BORDLEY WC, 1994, PEDIATRICS, V94, P376
[9]  
BROWN KS, 1996, SCIENTIST, P10
[10]  
*CDCP, 2000, MMWR-MORBID MORTAL W, V49, P2